Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000850598 | SCV000992825 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2017-12-31 | criteria provided, single submitter | clinical testing | |
Ro'ya Specialized Medical Laboratories, |
RCV000850598 | SCV001334139 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2020-05-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000850598 | SCV002555220 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000850598 | SCV004806153 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Biochemical Molecular Genetic Laboratory, |
RCV000850598 | SCV001132994 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2019-08-25 | no assertion criteria provided | clinical testing | |
OMIM | RCV000850598 | SCV002016242 | pathogenic | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome | 2021-11-17 | no assertion criteria provided | literature only |